MedTrace Logo

Pharmacokinetics of Vancomycin in the ICU in Renal Replacement Therapy

NCT00848809 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2015-04-22

No results posted yet for this study

Summary

This study is an observational analysis that monitors the effect of different dialysis methods on vancomycin levels when patients are critically ill. No changes are made to therapy based on levels, but levels are checked more frequently than normal. The primary dialysis methods being studied are SLED (slow-low efficiency daily) dialysis and intermittent hemodialysis. Vancomycin is the only medication being evaluated in this study. This study will provide detailed information on how to dose vancomycin in patients that are on dialysis in the intensive care unit.

Conditions

Interventions

PROCEDURE

Blood sample

9 blood samples will be sent to the laboratory for the subjects in the SLED cohort

PROCEDURE

Blood sample

10 blood samples will be collected and sent to the laboratory for the subjects in the intermittent hemodialysis cohort.

Sponsors & Collaborators

  • Avera McKennan Hospital & University Health Center

    lead OTHER

Principal Investigators

  • Bradley Beck, Pharm.D. · Avera McKennan Hospital and University Health Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00848809 on ClinicalTrials.gov